Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Hanwha Aerospace has disclosed a supply contract with the Defense Acquisition Program Administration (DAPA) valued at approximately KRW 709.3B for the 4th mass production batch of K21 Infantry Fighting Vehicles and 21 other items.
📊 [Key Disclosure Contents & Major Financial Figures]
1. Contract Details and Value
- Contract Type: Product Supply
- Contract Name: 4th Mass Production Batch of K21 Infantry Fighting Vehicles and 21 Other Items
- Contract Amount: KRW 709,290,211,760 (Approx. KRW 709.29B)
- Recent Annual Revenue: KRW 9,359,005,981,309 (Approx. KRW 9.36T, 2023 consolidated revenue)
- Proportion to Revenue: 7.58%
- Large Corporation Status: Applicable
2. Contract Partner and Key Terms
- Contract Partner: Defense Acquisition Program Administration (DAPA)
- Supply Region: South Korea
- Contract Period: December 17, 2024 – September 15, 2028
- Contract Date: December 17, 2024
- Payment Terms: Advance payment included; payment within 5 business days following billing after contract completion and inspection approval
3. Other Details
- Contract schedule and financial terms are subject to change during project execution.
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Monitoring Mass Production Execution and Revenue Recognition
This disclosure details a supply agreement with DAPA valued at approximately KRW 709.3B for K21 infantry fighting vehicles and additional defense items. As the delivery schedule extends through 2028, tracking smooth product deliveries and phased revenue recognition is important for evaluating the contract’s ongoing contribution. Detailed progress and potential term revisions can be verified in upcoming periodic reports under ‘Business Description (Order Status)’ and amendment filings.
📢 Disclaimer and Source Notice
Source: This content was newly generated and structured based on official data filed with the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).
Investment Risk Warning: This material is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific securities. All investment decisions and financial responsibilities rest entirely with the investor.
Inquiries: For compliance inquiries or copyright-related requests, please contact ksb220805@gmail.com.
